Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.378 DKK 1.17% Market Closed
Market Cap: 626.5m DKK

Relative Value

The Relative Value of one BIOPOR stock under the Base Case scenario is 1.051 DKK. Compared to the current market price of 1.378 DKK, Bioporto A/S is Overvalued by 24%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOPOR Relative Value
Base Case
1.051 DKK
Overvaluation 24%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
33
Median 3Y
19.2
Median 5Y
20.2
Industry
7.1
Forward
11.2
vs History
vs Industry
Median 3Y
-9.2
Median 5Y
-9.8
Industry
23
Forward
-7.2
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-9.9
Industry
19.4
vs History
vs Industry
Median 3Y
-8.7
Median 5Y
-9.3
Industry
23.1
vs History
23
vs Industry
14
Median 3Y
9.5
Median 5Y
10.7
Industry
2.6
vs History
73
vs Industry
29
Median 3Y
17.1
Median 5Y
19.4
Industry
7.5
Forward
10.7
vs History
68
vs Industry
24
Median 3Y
26.7
Median 5Y
29.6
Industry
9.4
vs History
vs Industry
Median 3Y
-8.2
Median 5Y
-8.5
Industry
4.4
vs History
vs Industry
Median 3Y
-7.9
Median 5Y
-8.1
Industry
4.5
Forward
-6.6
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.1
Industry
5.2
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.1
Industry
3.7
vs History
76
vs Industry
13
Median 3Y
22.4
Median 5Y
22
Industry
4.8

Multiples Across Competitors

BIOPOR Competitors Multiples
Bioporto A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Bioporto A/S
CSE:BIOPOR
592.1m DKK 17.2 -7.2 -6.4 -6.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 643 152.8 -164 653.8 -199 942.2 -197 660.6
US
Abbvie Inc
NYSE:ABBV
335.3B USD 5.8 80.7 15.4 22.7
US
Amgen Inc
NASDAQ:AMGN
156.1B USD 4.6 26.3 14.2 23.4
US
Gilead Sciences Inc
NASDAQ:GILD
140B USD 4.9 23.5 10.2 14.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.8B USD 10.4 -117.1 24.9 26.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 033.6 -518.9 -565.1 -550
AU
CSL Ltd
ASX:CSL
117.1B AUD 5 27.7 17.1 21.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
53.4B USD 3.8 11.9 10.5 11.7
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60.1 -64.7 -58.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
39.2B USD 16.7 -145.4 -650.3 -325.9
P/S Multiple
Revenue Growth P/S to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average P/S: 3 149 570.4
17.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 643 152.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.4
10%
1
US
E
Epizyme Inc
F:EPE
2 033.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
3.8
4%
0.9
US
S
Seagen Inc
F:SGT
19.6
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.7
29%
0.6
P/E Multiple
Earnings Growth PEG
DK
Bioporto A/S
CSE:BIOPOR
Average P/E: 34
Negative Multiple: -7.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 653.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.7
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -117.1 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -518.9 N/A N/A
AU
CSL Ltd
ASX:CSL
27.7
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.9
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -145.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBITDA: 15.4
Negative Multiple: -6.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 942.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.5
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -650.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBIT: 19.9
Negative Multiple: -6.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 660.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.7
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.4
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14.1
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550 N/A N/A
AU
CSL Ltd
ASX:CSL
21.4
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.7
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -325.9 N/A N/A